Cargando…
The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma
BACKGROUND: Soft tissue and bone sarcoma represent a broad spectrum of different pathology and genetic variance. Current chemotherapy regimens are derived from randomised trials and represent empirical treatment. Chemosensitivity testing and whole exome sequencing (WES) may offer personalized chemot...
Autores principales: | Calvert, Nicholas, Wu, Jiansha, Sneddon, Sophie, Woodhouse, Jennifer, Carey-Smith, Richard, Wood, David, Ingley, Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842605/ https://www.ncbi.nlm.nih.gov/pubmed/29541442 http://dx.doi.org/10.1186/s13569-018-0090-1 |
Ejemplares similares
-
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2017) -
In vitro chemosensitivity tests on xenografted human melanomas.
por: Bateman, A. E., et al.
Publicado: (1980) -
Whole exome sequencing in the rat
por: Foley, Julie F., et al.
Publicado: (2018) -
The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
por: Courtenay, V. D., et al.
Publicado: (1982) -
Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression
por: Xie, Tao, et al.
Publicado: (2015)